MediFind
LoginSign Up
Are we missing a condition or feature you’d like to see? MediFind is always evolving and we’d love your feedback.
MediFind
Condition

Acute Myeloblastic Leukemia with Maturation

Symptoms, Doctors, Treatments, Research & More

Condition 101

What are the alternative names for Acute Myeloblastic Leukemia with Maturation?

  • Acute myeloblastic leukemia type 2
  • Acute myeloblastic leukemia M2
  • AML M2
  • LAM M2
Learn More About This Condition

Top Global Doctors

View All Doctors

Latest Research

Latest Advance
Study
  • Condition: Acute Myeloid Leukemia in Children
  • Journal: Pediatric blood & cancer
  • Treatment Used: Fludarabin, Cytarabine, and Fractioned Gemtuzumab followed by Hematopoietic Stem Cell Transplantation
  • Number of Patients: 8
  • Published —
The study researched the outcomes between fludarabin, cytarabine, and fractioned gemtuzumab followed by hematopoietic stem cell transplantation for children with first-line refractory acute myeloid leukemia.
Latest Advance
Study
  • Condition: Bone Marrow (BM) Haploidentical Transplant
  • Journal: Cytotherapy
  • Treatment Used: Post-Transplantation Cyclophosphamide (PT-CY)
  • Number of Patients: 88
  • Published —
This study analyzed cell content data in patients receiving HLA haploidentical bone marrow (BM) transplants with post-transplantation cyclophosphamide (PT-CY).
Latest Advance
Study
  • Condition: Relapsed myelodisplastic syndrome/acute myeloid leukemia and high-risk acute myeloid leukemia
  • Journal: Zhongguo shi yan xue ye xue za zhi
  • Treatment Used: Decitabine combined with donor lymphocyte infusion
  • Number of Patients: 10
  • Published —
The study researched the effects of decitabine combined with donor lymphocyte infusion for relapsed myelodisplastic syndrome/acute myeloid leukemia and high-risk acute myeloid leukemia.
Latest Advance
Study
  • Condition: Low and Moderate-Risk Myelodysplastic Syndrome (MDS)
  • Journal: Zhongguo shi yan xue ye xue za zhi
  • Treatment Used: Decitabine
  • Number of Patients: 47
  • Published —
This study investigated the effectiveness of decitabine in the treatment of patients with low-risk and moderate-risk myelodysplastic syndrome (MDS) and to analyze the prognostic factors.
View All Latest Research

Clinical Trials

Clinical Trial
Dietary Supplement
  • Status: Recruiting
  • Study Type: Dietary Supplement
  • Participants: 74
  • Start Date: December 1, 2020
Effect of a Hyperproteic Hyperenergetic Enteral Formula on Body Composition, Muscle Strength and Concentration of Vascular Endothelial Growth Factor (VEGF) in Patients With Actue Myeloid Leukemia (AML) During the Hospital Stay
Clinical Trial
Drug
  • Status: Recruiting
  • Study Type: Drug
  • Participants: 72
  • Start Date: October 3, 2020
CLAG·M Chemotherapy Followed Immediately by Related/Unrelated Reduced-Intensity Conditioning (RIC) Allogeneic Hematopoietic Cell Transplantation for Adults With Myeloid Malignancies at High Risk of Relapse: A Phase 1 Study
Clinical Trial
Drug
  • Status: Recruiting
  • Study Type: Drug
  • Participants: 38
  • Start Date: July 28, 2020
An Open-Label Phase IB/II Study of Magrolimab in Combination With Azacitidine and Venetoclax for the Treatment of Patients With Acute Myeloid Leukemia (AML)
Clinical Trial
Drug
  • Status: Recruiting
  • Study Type: Drug
  • Participants: 86
  • Start Date: July 27, 2020
A Phase II Multi-center, Single Arm, Safety and Efficacy Study of MBG453 in Combination With Azacitidine and Venetoclax for the Treatment of Acute Myeloid Leukemia (AML) in Adult Patients Unfit for Chemotherapy
View All Clinical Trials